四氢-1-(4-哌啶基)-2(1h)-嘧啶酮结构式
|
常用名 | 四氢-1-(4-哌啶基)-2(1h)-嘧啶酮 | 英文名 | 1-(4-Piperidinyl)tetrahydro-2(1H)-pyrimidinone |
---|---|---|---|---|
CAS号 | 61220-36-8 | 分子量 | 183.251 | |
密度 | 1.1±0.1 g/cm3 | 沸点 | 397.2±31.0 °C at 760 mmHg | |
分子式 | C9H17N3O | 熔点 | N/A | |
MSDS | N/A | 闪点 | 194.0±24.8 °C |
中文名 | 四氢-1-(4-哌啶基)-2(1h)-嘧啶酮 |
---|---|
英文名 | 1-piperidin-4-yl-1,3-diazinan-2-one |
英文别名 | 更多 |
密度 | 1.1±0.1 g/cm3 |
---|---|
沸点 | 397.2±31.0 °C at 760 mmHg |
分子式 | C9H17N3O |
分子量 | 183.251 |
闪点 | 194.0±24.8 °C |
精确质量 | 183.137161 |
PSA | 47.86000 |
LogP | 0.17 |
蒸汽压 | 0.0±0.9 mmHg at 25°C |
折射率 | 1.513 |
~96% 四氢-1-(4-哌啶基)-2(... 61220-36-8 |
文献:SCHERING CORPORATION Patent: EP1144402 B1, 2004 ; Location in patent: Page 28; 31 ; EP 1144402 B1 |
~97% 四氢-1-(4-哌啶基)-2(... 61220-36-8 |
文献:Fujimoto, Takuya; Imaeda, Yasuhiro; Konishi, Noriko; Hiroe, Katsuhiko; Kawamura, Masaki; Textor, Garret P.; Aertgeerts, Kathleen; Kubo, Keiji Journal of Medicinal Chemistry, 2010 , vol. 53, # 9 p. 3517 - 3531 |
~% 四氢-1-(4-哌啶基)-2(... 61220-36-8 |
文献:Zeneca Limited Patent: US5889024 A1, 1999 ; |
四氢-1-(4-哌啶基)-2(1h)-嘧啶酮上游产品 3 | |
---|---|
四氢-1-(4-哌啶基)-2(1h)-嘧啶酮下游产品 0 |
piperidinyldiazinanone |
1-(4-Piperidinyl)tetrahydro-2(1H)-pyrimidinone |
1-(piperidin-4-yl)tetrahydropyrimidin-2-one |
1-(4-piperidyl)-2-oxo-hexahydro-pyrimidine |
1-piperidinyl-4-yltetrahydropyrimidin-2[lH]-one |
4-(2-oxoperhydropyrimidine-1-yl)piperidine |
4-(tetrahydro-2-oxo-1(2H)-pyrimidinyl)piperidine |
2(1H)-Pyrimidinone,tetrahydro-1-(4-piperidinyl) |
Tetrahydro-1-(4-piperidinyl)-2(1H)-pyrimidinone |
2(1H)-Pyrimidinone, tetrahydro-1-(4-piperidinyl)- |
1-(piperidin-4-yl)tetrahydropyrimidin-2(1H)-one |